GlaxoSmithKline Phils Inc - search results

European Union - English - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.

Philippines - English - FDA (Food And Drug Administration)

malanil 62.5mg/25mg tablet

glaxosmithkline phils inc - atovaquone / proguanil hydrochloride - tablet - 62.5mg/25mg

Philippines - English - FDA (Food And Drug Administration)

fluarix 15mcg / 0.5ml suspension for injection im/sc

glaxosmithkline phils inc - influenza vaccine (split virion, inactivated) northern hemisphere 2013-2014 strain - suspension for injection im/sc - 15mcg / 0.5ml

Philippines - English - FDA (Food And Drug Administration)

lamictal xr 100mg tablet, extended release

glaxosmithkline phils inc - lamotrigine - tablet, extended release - 100mg

Philippines - English - FDA (Food And Drug Administration)

lamictal xr 300mg tablet, extended release

glaxosmithkline phils inc - lamotrigine - tablet, extended release - 300mg

Philippines - English - FDA (Food And Drug Administration)

lamictal xr 200mg tablet, extended release

glaxosmithkline phils inc - lamotrigine - tablet, extended release - 200mg

Philippines - English - FDA (Food And Drug Administration)

lamictal xr 25mg tablet, extended release

glaxosmithkline phils inc - lamotrigine - tablet, extended release - 25mg